167 related articles for article (PubMed ID: 32156290)
1. Identification of key differentially expressed genes and gene mutations in breast ductal carcinoma in situ using RNA-seq analysis.
Zhu C; Hu H; Li J; Wang J; Wang K; Sun J
World J Surg Oncol; 2020 Mar; 18(1):52. PubMed ID: 32156290
[TBL] [Abstract][Full Text] [Related]
2. RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target.
Kaur H; Mao S; Li Q; Sameni M; Krawetz SA; Sloane BF; Mattingly RR
PLoS One; 2012; 7(12):e50249. PubMed ID: 23236365
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Lee S; Stewart S; Nagtegaal I; Luo J; Wu Y; Colditz G; Medina D; Allred DC
Cancer Res; 2012 Sep; 72(17):4574-86. PubMed ID: 22751464
[TBL] [Abstract][Full Text] [Related]
4. Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
Ropri AS; DeVaux RS; Eng J; Chittur SV; Herschkowitz JI
Breast Cancer Res; 2021 Oct; 23(1):101. PubMed ID: 34717732
[TBL] [Abstract][Full Text] [Related]
5. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-Seq data.
Zhang Z; Wu H; Zhou H; Gu Y; Bai Y; Yu S; An R; Qi J
Oncol Lett; 2018 Apr; 15(4):4550-4556. PubMed ID: 29616087
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the breast ductal carcinoma in situ signature and its prognostic implications.
Zhang J; Lin H; Hou L; Xiao H; Gong X; Guo X; Cao X; Liu Z
Cancer Med; 2023 Feb; 12(3):3758-3772. PubMed ID: 35880695
[TBL] [Abstract][Full Text] [Related]
8. Analysis of gene expression in ductal carcinoma in situ of the breast.
Adeyinka A; Emberley E; Niu Y; Snell L; Murphy LC; Sowter H; Wykoff CC; Harris AL; Watson PH
Clin Cancer Res; 2002 Dec; 8(12):3788-95. PubMed ID: 12473591
[TBL] [Abstract][Full Text] [Related]
9. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
12. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
13. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
[TBL] [Abstract][Full Text] [Related]
14. Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.
Rossetti S; Bshara W; Reiners JA; Corlazzoli F; Miller A; Sacchi N
Cancer Lett; 2016 Oct; 380(2):375-383. PubMed ID: 27422542
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation.
Shah S; Brock EJ; Jackson RM; Ji K; Boerner JL; Sloane BF; Mattingly RR
Neoplasia; 2018 Sep; 20(9):951-963. PubMed ID: 30144784
[TBL] [Abstract][Full Text] [Related]
16. Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
Bergholtz H; Kumar S; Wärnberg F; Lüders T; Kristensen V; Sørlie T
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1248. PubMed ID: 32671987
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
18. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
Abba MC; Gong T; Lu Y; Lee J; Zhong Y; Lacunza E; Butti M; Takata Y; Gaddis S; Shen J; Estecio MR; Sahin AA; Aldaz CM
Cancer Res; 2015 Sep; 75(18):3980-90. PubMed ID: 26249178
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
[TBL] [Abstract][Full Text] [Related]
20. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
Scribner KC; Behbod F; Porter WW
Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
